Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 310 Records) |
Query Trace: Neoplasms and CYP2D6[original query] |
---|
Impact of cytochrome P450 2D6 polymorphisms on decision-making and clinical outcomes in adjuvant hormonal therapy for breast cancer. World journal of clinical oncology 2022 9 13 (8): 712-724. Tan Ern-Yu, Bharwani Lavina, Chia Yee-Hong, Soong Richie C T, Lee Sherylyn S Y, Chen Juliana J C, Chan Patrick M |
Detection of relevant pharmacogenetic information through exome sequencing in oncology. Pharmacogenomics 2022 8 23 (14): 759-770. Verdez Simon, Albuisson Juliette, Duffourd Yannis, Boidot Romain, Reda Manon, Thauvin-Robinet Christel, Fumet Jean-David, Ladoire Sylvain, Nambot Sophie, Callier Patrick, Faivre Laurence, Ghiringhelli François, Picard Nicol |
CYP2D6 and CYP2E1 Gene Polymorphisms and their Association with Cervical Cancer Susceptibility: A Hospital Based Case-Control Study from South-Western Maharashtra. Asian Pacific journal of cancer prevention : APJCP 2022 Aug 23 (8): 2591-2597. Datkhile Kailas D, Durgawale Pratik P, Gudur Rashmi A, Gudur Anand K, Patil Satish |
Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities. Anti-cancer drugs 2022 Aug . Kwok Wang Chun, Lam David Chi Leung, Ip Mary Sau Man, Tam Terence Chi Chun, Ho James Chung M |
Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk. Translational lung cancer research 2022 Apr 11 (4): 509-522. Fu Rui, Zhang Jia-Tao, Chen Rong-Rong, Li Hong, Tai Zai-Xian, Lin Hao-Xiang, Su Jian, Chu Xiang-Peng, Zhang Chao, Qiu Zhen-Bin, Chen Zi-Hao, Tang Wen-Fang, Dong Song, Yang Xue-Ning, Zhang Guo-Qing, Zhao Guo-Ping, Wu Yi-Long, Zhong Wen-Zh |
Value of therapeutic drug monitoring of endoxifen in Egyptian premenopausal patients with breast cancer given tamoxifen adjuvant therapy: A pilot study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022 12 10781552221146531. El Desoky Ehab S, Taha Amira F, Mousa Heba Salah, Ibrahim Abeer, Saleh Medhat A, Abdelrady Mohamed A, Hareedy Mohammad Sal |
Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study. BMC pulmonary medicine 2022 11 22 (1): 454. Nio Yuta, Ishida Hiroo, Matsumoto Natsumi, Kusumoto Sojiro, Kubota Yutaro, Tsunoda Takuya, Sasaki Yasutsuna, Fujita Ken-Ic |
Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics 2022 11 33 (1): 10-18. Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard |
The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients. BMC cancer 2022 Oct 22 (1): 1067. Ismail Al-Khalil Wouroud, Al-Salhi Lana, Rijjal Sara, Aljamali Majd, Youssef Lama |
CYP2D6-guided opioid therapy for adults with cancer pain: a randomized implementation clinical trial. Pharmacotherapy 2023 9 . Scott A Mosley, Emily Cicali, Alex Del Cueto, Diane G Portman, Kristine A Donovan, Yan Gong, Taimour Langaee, Priya Gopalan, Jessica Schmit, Jason S Starr, Natalie Silver, Young D Chang, Sahana Rajasekhara, Joshua E Smith, Heloisa P Soares, Mike Clare-Salzler, Petr Starostik, Thomas J George, Howard L McLeod, Roger B Fillingim, J Kevin Hicks, Larisa H Cavalla |
Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes. Cancer research and treatment 2023 8 . Xin Li, Zehao Li, Lin Li, Tong Liu, Cheng Qian, Yanlv Ren, Zhigao Li, Kejin Chen, Dongchen Ji, Ming Zhang, Jinsong Wa |
Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort. British journal of clinical pharmacology 2023 6 . Bianza Tinotenda Mbavha, Roslyn Stella Thelingwani, Zedias Chikwambi, Anna Mary Nyakabau, Collen Masimirembwa, |
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta pharmaceutica (Zagreb, Croatia) 2023 6 73 (2): 227-241. Javier Muriel, Mónica Escorial, César Margarit, Jordi Barrachina, Cristian Carvajal, Domingo Morales, Ana M Pei |
Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients. Pharmacogenomics 2023 5 . Abdullah Alsulaiman, Hoyin Chu, Mohammed Al-Jumaan, Mohammed Alyahya, Yousef Al Marzooq, Fatmah Almulhim, Chittibabu Vatte, Areej Alnimer, Afnan Almuhanna, Amein Al-Ali, Saud H AlDubay |
Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis. Breast (Edinburgh, Scotland) 2023 4 69 342-348. Blancas Isabel, Linares-Rodríguez Marina, Martínez de Dueñas Eduardo, Herrero-Vicent Carmen, Molero-Mir María D, Garrido José M, Rodríguez-Serrano Fernan |
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma. Cancer 2023 4 . Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Miguel Nogué, Isabel Busquier, Fernando Arias, Fernando López-Campos, Ana Fernández-Montes, Ana Ruiz, Concepción Velázquez, Celia Martín-Bravo, Elisabeth Pérez-Ruiz, Elena Asensio, Xavier Hernández-Yagüe, Aline Rodrigues, Ismael Ghanem, Rocío López-Vacas, Ahmed Hafez, Pedro Arias, Irene Dapía, Mario Solís, Antje Dittmann, Ricardo Ramos, Carlos Llorens, Joan Maurel, Ángel Campos-Barros, Juan Ángel Fresno Vara, Jaime Fel |
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer. Breast cancer research and treatment 2023 4 . Souwer E T D, Sanchez-Spitman A, Moes D J A R, Gelderblom H, Swen J J, Portielje J E A, Guchelaar H J, van Gelder |
Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 2 160 114369. Agema Bram C, Buijs Sanne M, Sassen Sebastiaan D T, Mürdter Thomas E, Schwab Mathias, Koch Birgit C P, Jager Agnes, van Schaik Ron H N, Mathijssen Ron H J, Koolen Stijn L |
Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D6*17 Variant on the Formation of the Active Metabolite, Endoxifen. Journal of personalized medicine 2023 2 13 (2): . Kanji Comfort Ropafadzo, Nyabadza Georginah, Nhachi Charles, Masimirembwa Coll |
Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi Long-Read and Illumina Short-Read Sequencing. Journal of personalized medicine 2023 12 13 (12): . David Barthélémy, Elodie Belmonte, Laurie Di Pilla, Claire Bardel, Eve Duport, Veronique Gautier, Léa Pay |
Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study. BMC pharmacology & toxicology 2023 11 24 (1): 64. Jing Yang, Ying-Zi Sun, Qun-Fang Li, Zheng Fu, Yu-Yao Guan, Chao Song, Lei Zhe |
Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis 2023 11 238 115839. Fatemeh Saghafi, Ebrahim Salehifar, Pouneh Ebrahimi, Mohammad Reza Shiran, Ehsan Zaboli, Seyed Mojtaba Sohrevardi, Tannaz Jamialahmadi, Adeleh Sahebnasagh, Amirhossein Sahebk |
CYP2D6 genotyping and the clinical impact on outcomes in breast cancer tamoxifen-treated patients. Personalized medicine 2023 11 . Gabriel Ramírez, Marcelo Vital, Carolina Vergara, Florencia Carusso, Florencia Neffa, Adriana Della Valle, Patricia Esper |
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The pharmacogenomics journal 2023 1 . Gillis Nancy, Etheridge Amy S, Patil Sushant A, Hayes D Neil, Hayward Michele C, Auman J Todd, Parker Joel S, Innocenti Federi |
Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 2023 1 27 (6): 1058-1076. Rajabi-Moghaddam Mahdieh, Abbaszadeh Ham |
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.
Clinical pharmacology and therapeutics 2023 1 113 (3): 712-723. Khor Chiea Chuen, Winter Stefan, Sutiman Natalia, Mürdter Thomas E, Chen Sylvia, Lim Joanne Siok Liu, Li Zheng, Li Jingmei, Sim Kar Seng, Ganchev Boian, Eccles Diana, Eccles Bryony, Tapper William, Zgheib Nathalie K, Tfayli Arafat, Ng Raymond Chee Hui, Yap Yoon Sim, Lim Elaine, Wong Mabel, Wong Nan Soon, Ang Peter Cher Siang, Dent Rebecca, Tremmel Roman, Klein Kathrin, Schaeffeler Elke, Zhou Yitian, Lauschke Volker M, Eichelbaum Michel, Schwab Matthias, Brauch Hiltrud B, Chowbay Balram, Schroth Wern |
Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach. Minerva anestesiologica 2024 4 . Mónica Escorial, Javier Muriel, Laura Agulló, Thomas Zandonai, César Margarit, Domingo Morales, Ana M Pei |
Comprehensive analysis of the role of cuproptosis-related genes in the prognosis and immune infiltration of adrenocortical Carcinoma. Heliyon 2024 1 10 (1): e23661. Zhiyuan You, Jiqing He, Zhongming G |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: